The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial
2025 · BMJ · 18 citations
https://doi.org/10.1136/bmj-2024-082583
J
Jianfeng Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
810
Citations
15
h-index
23
i10-index
Jianfeng Wu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Hepatitis B Virus Studies & Lung Cancer Diagnosis and Treatment & Head and Neck Cancer Studies. The author has an h-index of 15, co-authored 54 publications.
Papers by this author
worksIn situ correction of various β-thalassemia mutations in human hematopoietic stem cells
2024 · Frontiers in Cell and Developmental Biology · 7 citations
https://doi.org/10.3389/fcell.2023.1276890
Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial
2025 · Cancer Immunology Immunotherapy · 5 citations
https://doi.org/10.1007/s00262-024-03934-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat